For a while, there were none. Suddenly, there were two.
Bicara Therapeutics filed Thursday afternoon for an initial public offering, just …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve
The FDA acknowledged today that it’s been allowing temporary imports of the commonly used cancer drug cisplatin from Fresenius Kabi to help shore up the
In March 2024, Madrigal Pharmaceuticals had a breakthrough moment when, after years of research and anticipation, the US Food and Drug Administration (FDA) granted approval